SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000904454-16-001515
Filing Date
2016-10-18
Accepted
2016-10-18 16:16:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A - AMENDMENT NO. 4 FOR ARGOS THERAPEUTICS, INC. BY PHARMSTANDARD I s13da_100716-argos.htm SC 13D/A 102659
  Complete submission text file 0000904454-16-001515.txt   104171
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Subject) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88006 | Film No.: 161941040
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528
Business Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528 352 26449 557
Pharmstandard International S.A. (Filed by) CIK: 0001598762 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A